Keyphrases
Acute Lung Injury
100%
Acute Respiratory Distress Syndrome
100%
Exhaled Nitric Oxide
66%
Confidence Interval
43%
Clinical Analysis
42%
Bleeding Risk
42%
Risk of Bias
36%
Critically Ill Patients
36%
Secondary Prevention
33%
Percutaneous Coronary Intervention
33%
Indwelling Central Venous Catheter
33%
Surgeons
33%
Treatment Discontinuation
33%
Systematic Meta-analysis
33%
Antiplatelet Therapy
33%
Surgical Procedures
33%
Noncardiac Surgery
33%
Aerosolized Prostacyclin
33%
Dual Antiplatelet Therapy
33%
Aspirin
33%
Antithrombin III (ATIII)
33%
Circulatory Collapse
33%
Cardiovascular Prevention
33%
Stent Thrombosis
33%
Risk Ratio
33%
Clopidogrel
33%
Myocardial Infarction
33%
Anesthesiologist
33%
Bleeding Patients
33%
Anesthesia
33%
Surgical Patients
33%
I2 Statistic
31%
Subgroup Analysis
26%
Anabolic Steroids
22%
Oxygenation
21%
Randomized Clinical Trial
21%
Sensitivity Analysis
20%
Spinal Needle
19%
Ongoing Trials
18%
Randomized Controlled Trial
18%
Fixed Effects Model
18%
Relative Risk
17%
Indwelling Time
16%
Physiological Outcomes
15%
High Risk
15%
Medicine and Dentistry
Acute Lung Injury
66%
Sequential Analysis
39%
Antiplatelet
33%
Shock (Circulatory)
33%
Lumbar Puncture
33%
Diagnosis
33%
Antithrombin III
33%
Fibrinogen Concentrate
33%
Acute Respiratory Distress Syndrome
33%
Nitric Oxide
33%
Anabolic Agent
33%
Systematic Review with Meta-Analysis
33%
Subgroup Analysis
19%
Randomized Controlled Trial
18%
Bleeding
16%
Surgical Technique
16%
Cardiovascular System
16%
Myocardial Infarction
16%
Prematurity
16%
Acetylsalicylic Acid
16%
Noncardiac Surgery
16%
Percutaneous Coronary Intervention
16%
Side Effect
16%
Clopidogrel
16%
Stent Thrombosis
16%
Anesthesiologist
16%
Secondary Prevention
16%
Surgeon
16%
Nursing and Health Professions
Acute Lung Injury
66%
Sequential Analysis
43%
Anabolic Agent
33%
Shock
33%
Adult Respiratory Distress Syndrome
33%
Prostacyclin
33%
Antithrombin III
33%
Systematic Review with Meta-Analysis
33%
Nitric Oxide
33%
Spinal Needle
22%
Confidence Interval
17%
